[Methylphenidate and secondary Raynaud's phenomenon]

Area of Science:

• Vascular Medicine
• Pharmacology

Background:

• Raynaud's phenomenon is a vascular disorder causing episodic vasoconstriction in extremities.
• It presents as primary (idiopathic) or secondary to other conditions or medications.
• Secondary Raynaud's is often linked to connective tissue diseases and certain drugs.

Observation:

• The abstract describes a case of Raynaud's phenomenon.
• This instance was secondary to methylphenidate use.
• The patient was a 14-year-old individual.

Findings:

• Methylphenidate, a sympathomimetic drug, can induce secondary Raynaud's phenomenon.
• Vasoconstrictive effects of certain medications are a known cause of secondary Raynaud's.
• This case illustrates a specific drug-induced etiology.

Implications:

• Clinicians should consider medication side effects, including methylphenidate, in diagnosing secondary Raynaud's phenomenon.
• Awareness of drug-induced vasoconstriction is crucial for managing Raynaud's.
• This finding contributes to understanding iatrogenic causes of vascular events.